Risk Warning: Leveraged products carry a high level of risk and may result in the loss of all your capital. Ensure you fully understand the risks before investing.
Risk Warning: Leveraged products carry a high level of risk and may result in the loss of all your capital. Ensure you fully understand the risks before investing.

Current region:

  • English
    ACTIVE
Other languages:
  • Español – Spanish
  • Português – Portuguese
  • English – International
  • Tiếng Việt – Vietnamese
  • Français – French
  • ไทย – Thai
  • العربية – Arabic
Risk Warning: Leveraged products carry a high level of risk and may result in the loss of all your capital. Ensure you fully understand the risks before investing.
Technical Analysis-EN

Global Equities Rise on Dollar Weakness

The global spotlight is turning toward Asia this week, with several high-level meetings scheduled between the United States and key

Featured-DailyTechnical-EN

S&P 500: Assessing the Rebound

Last week was, overall, quite positive for equity indices and the global benchmark. After an initial rebound attempt that quickly

Featured-DailyTechnical-EN

U.S. Indices Close Flat as Middle East Tensions Rise

We appreciate our readers’ patience as we defer our oil analysis by one more day and we are committed to

Featured-DailyTechnical-EN

NVIDIA Report Earnings After the Closing Bell 

Yesterday’s session, ahead of the highly anticipated earnings release from NVIDIA—as is often the case, among the last of the

Featured-DailyTechnical-EN

US500 Slips Below Key 6,830 Support

It has not been a good month so far for the US500 (S&P 500), and we are only on February

Featured-DailyTechnical-EN

Eli Lilly Holds Firm in the USD 1 Trillion Club

On Friday, 21 November 2025, Eli Lilly became the first pharmaceutical company to reach a valuation typically reserved for major